Press release
Cell and Gene Therapy Bioassay Services Market expected to Witness Huge Revenue Growth to 2031
The Cell and Gene Therapy Bioassay Services Market Size is valued at 1.84 Billion in 2022 and is predicted to reach 5.64 Billion by the year 2030 at a 15.3 % CAGR during the forecast period for 2023-2030.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1208
Cell and gene therapies involve removing protein, cells, or genetic material from a patient or donor and modifying it to deliver highly targeted or personalized treatment. These medicines can potentially address complicated and rare diseases while providing longer-term advantages than traditional treatments. As a result, the need for diverse contract research organizations that offer bioassay services for cell and gene therapies has grown over time.
Numerous factors, such as the growing need for enhanced medical treatments, the rising incidence of cancer and other chronic diseases, and advances in genomics technology methodologies, are primarily driving market expansion. Increasing demand for personalized medicines and increased government investment in the R&D of new cell and gene therapies are expected to drive demand for bioassay services over the forecast period. Because of the growing demand for cost-effective and efficient cell and gene therapies, contract research organizations (CROs) have increased their bioassay services, creating market development potential shortly.
As the demand for outsourcing bioanalytical services rises, numerous contract research firms claiming to provide bioassay services for cell and gene therapies have emerged. However, the high cost of bioassay services may limit the worldwide cell and gene therapy bioassay services market's growth in the upcoming years.
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1208
North America is anticipated to be the major contributor to the Cell and Gene Therapy Bioassay Services Market because of the increasing number of cell and gene therapy product launches and increased R&D activity in biopharma businesses to create cell and gene treatments. In addition, the Asia Pacific regional market is expected to register significant growth because of the high frequency of chronic diseases and genetic abnormalities, the growing older population, patients' increasing need for tailored treatments, and improved technological advances.
Major market players operating in the Cell and Gene Therapy Bioassay Services Market include AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Pacific BioLabs (US), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Lonza (Switzerland), Porton Biopharma Ltd (UK), WuXi Advanced Therapies (US), Avomeen (US), Charles River Laboratories (US), Absorption Systems (US), BioAgilytix Labs (US), Catalent, Inc (US), Svar Life Science AB (Sweden), and others.
Recent collaborations and agreements in the market:
• In December 2021, CCRM Enterprises Inc., the company's venture capital arm, purchased Mediphage Bioceuticals, Inc. The investment by CCRM Enterprises will be utilized to fund the development and operation of the technology, as well as access to CCRM's scientific and industrial knowledge. Mediphage is concentrating on developing a non-viral gene therapy platform that will pave the way for individualized genetic treatment that is both safe and effective while also resolving many of the shortcomings of current viral vector-based technologies.
• In April 2021, AavantiBio (US), a gene therapy firm, and Catalent (US), a drug, cell, and gene therapy supplier, collaborated to support the development and manufacture of AavantiBio's gene treatments.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1208
Market Segments
Global Cell and Gene Therapy Bioassay Services Market, by Type of Therapy, 2022-2030 (Value US$ Mn)
• Cell Therapy
• Gene Therapy
Global Cell and Gene Therapy Bioassay Services Market, by Therapeutic Area, 2022-2030 (Value US$ Mn)
• Oncological
• Infectious
• Autoimmune
• Rare / Genetic
• Cardiovascular
• Metabolic
• Blood
• Neurological
• Ophthalmic Disorders
• Other Therapeutic Areas
Global Cell and Gene Therapy Bioassay Services Market, by Scale of Operation, 2022-2030 (Value US$ Mn)
• Discovery
• Preclinical
• Clinical
Global Cell and Gene Therapy Bioassay Services Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Cell and Gene Therapy Bioassay Services Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
> To receive a comprehensive analysis of the prospects for the global Cell and Gene Therapy Bioassay Services Market
> To receive an industry overview and future trends of the Cell and Gene Therapy Bioassay Services Market
> To analyze the Cell and Gene Therapy Bioassay Services Market drivers and challenges
> To get information on the Cell and Gene Therapy Bioassay Services Market value (US$ Mn) forecast to 2030
> Significant investments, mergers & acquisitions in the
For More Information: https://www.insightaceanalytic.com/report/global-cell-and-gene-therapy-bioassay-services-market/1208
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Site Visit: www.insightaceanalytic.com
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell and Gene Therapy Bioassay Services Market expected to Witness Huge Revenue Growth to 2031 here
News-ID: 3334231 • Views: …
More Releases from Insightace analytic
Cellular Health Screening Market Exclusive Report on Current Trends and Future I …
The Cellular Health Screening Market Size is valued at 2.33 Billion in 2023 and is predicted to reach 4.67 Billion by the year 2031 at a 9.31 % CAGR during the forecast period for 2024-2031.
Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1391
Market Synopsis-
A market evaluation report on the Cellular Health Screening Market has been released, from InsightAce Analytic"Global Cellular Health Screening Market By Test (Single Test Panels(Telomere Tests, Oxidative Stress…
Multiple Cancer Monoclonal Antibodies Market is on an Upward Growth Curve
A market evaluation report on the Multiple Cancer Monoclonal Antibodies Market has been released, from InsightAce Analytic "Global Multiple Cancer Monoclonal Antibodies Market- by Product Type (Cetuximab, Nivolumab, Atezolizumab, Ramucirumab, Pembrolizumab, Pembrolizumab Companion Diagnostic, Ipilimumab and Cancer Biosimilar Drugs (Bevacizumab, Trastuzumab, Nimotuzumab, etc.)), Indication Type (Lung Cancer, Bladder Cancer, Breast cancer, Endometrial cancer, Ovarian cancer, Oesophageal cancer, Prostate cancer, Multiple Myeloma, Lymphoma, Renal Cell Cancer and Others), Trends, Industry Competition…
Autoinjector Contract Manufacturing Market Report- Expansive Coverage on the Pro …
A market evaluation report on the Autoinjector Contract Manufacturing Market has been released, from InsightAce Analytic "Global Autoinjector Contract Manufacturing Market- by Product (Disposable Autoinjectors, Reusable Autoinjectors, Wearable Injector and Smart/Connected Autoinjectors), Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis. Diabetes and Others), End-User (Homecare, Hospitals & Clinics and Ambulatory Services), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1340
The release of a market assessment…
Advanced Empty Capsule market Future Trends and Scope Analysis Report
A market evaluation report on the Advanced Empty Capsule Market has been released, from InsightAce Analytic "Global Advanced Empty Capsule Market- by Product (Oral Capsules and Inhalation Capsules), Raw Material (Animal Source and Vegetarian-based), Capsule Size (Size "000" Capsules, Size "00" Capsules, Size "0" Capsules, Size "1" Capsules, Size "2" Capsules, Size "3" Capsules, Size "4" Capsules and Size "5" Capsules), End-Users (Pharmaceutical, Nutraceutical & Cosmetic, CROs and CMOS), Trends,…
More Releases for Therapy
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created…
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights:
• Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026
• Cell Therapy Clinical Trial Insight by Indication, Company & Country
• Global Cell Therapy Clinical Pipeline: 767 Cell Therapies
• Globally Marketed Cell Therapies: 25 Cell Therapies
• Maximum Number of Marketed Cell Therapies In USA: 15 Therapies
• Price & Product Insight By Region/Country
• Regional Analysis of the Cell Therapy Market
Download…
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,…
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with…
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023.
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand…
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market.
Factors that are likely to hamper the growth of the market…
